Overall, the current study has added crucial pathological and molecular evidence on a pro‐tumorigenic and pro‐metastatic role of the integrin‐FAK axis in CRC and boosted its potential as a therapeutic target (Figure 7H). Here, PTK2 is linked to colorectal carcinoma.